1. Home
  2. ELUT vs ALUR Comparison

ELUT vs ALUR Comparison

Compare ELUT & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.02

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.46

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
ALUR
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
18.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ELUT
ALUR
Price
$1.02
$1.46
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$7.00
$9.25
AVG Volume (30 Days)
420.5K
108.8K
Earning Date
03-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,746,000.00
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.47
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.50
$1.02
52 Week High
$3.46
$7.12

Technical Indicators

Market Signals
Indicator
ELUT
ALUR
Relative Strength Index (RSI) 67.58 45.62
Support Level $0.89 $1.28
Resistance Level $1.08 $1.57
Average True Range (ATR) 0.12 0.16
MACD 0.02 -0.03
Stochastic Oscillator 72.38 27.69

Price Performance

Historical Comparison
ELUT
ALUR

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: